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Abstract
 
Endo/lysosomal proteases control two key events in antigen (Ag) presentation: the degradation
of protein Ag and the generation of peptide-receptive major histocompatibility complex
(MHC) class II molecules. Here we show that the proinflammatory cytokines tumor necrosis
 
factor 
 
a
 
 and interleukin (IL)-1
 
b
 
 rapidly increase the activity of cathepsin (cat) S and catB in
human dendritic cells (DCs). As a consequence, a wave of MHC class II sodium dodecyl sulfate
stable dimer formation ensues in a catS-dependent fashion. In contrast, the antiinflammatory
cytokine IL-10 renders DCs incapable of upregulating catS and catB activity and in fact, atten-
uates the level of both enzymes. Suppressed catS and catB activity delays MHC class II sodium
dodecyl sulfate stable dimer formation and impairs Ag degradation. In DCs exposed to tetanus
toxoid, IL-10 accordingly reduces the number of MHC class II–peptide complexes accessible
to tetanus toxoid–specific T cell receptors, as analyzed by measuring T cell receptor downreg-
ulation in Ag-specific T cell clones. Thus, the control of protease activity by pro- and antiin-
flammatory cytokines is an essential feature of the Ag presentation properties of DCs.
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Introduction
 
During their transition from an immature to a mature state,
 
dendritic cells (DCs)
 
1
 
 acquire the unique ability to stimu-
late immunologically naive T cells. Maturation of DCs is a
process initiated by cellular activation and is manifested in
cells treated with proinflammatory cytokines (1–3). Upon
activation, DCs lose their ability to take up external Ags
but begin to export peptide-loaded MHC products to the
cell surface. Within T cell areas of lymphoid organs, fully
mature DCs abundantly display MHC molecules loaded
with antigenic peptides together with costimulatory signals.
The coordinated delivery of both signals to T cells ensures
the induction of a productive T cell response (2, 3). At least
some aspects of cytokine-induced DC maturation are
counteracted by antiinflammatory stimuli (4).
In the MHC class II presentation pathway, lysosomal
proteases of the cathepsin (cat) family control the process-
ing of Ag and the formation of peptide-receptive class II
dimers (5). The nature of these cats is a matter of debate.
Specific proteases may be dedicated to the presentation of
certain Ags: asparaginyl endopeptidase is involved in the
degradation of tetanus toxin by B lymphoblasts (6). While
the role of this protease in human DCs remains to be estab-
lished, it is reasonable to suggest that additional proteases
are critical for Ag degradation. In fact, catB is viewed as an
exopeptidase responsible for the degradation of peptides,
proteins, toxins, and cell surface receptors that enter the
cell via endo- or phagocytosis (7–9).
The digestion of the invariant chain (Ii) is a central step
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Abbreviations used in this paper:
 
 cat, cathepsin; CLIP, class II–associated
Ii-derived peptide; Cy C, cystatin C; DC, dendritic cell; HLA, histocom-
 
patibility leukocyte antigen; Ii, invariant chain; LHVS, 
 
N
 
-morpholinurea-
leucine-homophenylalanine-vinylsulfone-phenyl; LIP, leupeptin-induced
Ii peptide; md, monocyte-derived; MFI, mean fluorescence intensity; OG,
 
oregon green; SLIP, small leupeptin-induced Ii peptide; TCC, T cell
clone; TT, tetanus toxoid. 
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in class II–dependent Ag presentation, since it is a prerequi-
site for the formation of peptide-occupied SDS stable class
II 
 
ab
 
 dimers. The stepwise proteolytic degradation of Ii in
endo/lysosomal compartments generates a heterogeneous
set of 
 
z
 
3-kD fragments, termed class II–associated Ii-derived
peptides (CLIPs), which remain bound to the class II
binding groove until exchanged for antigenic peptides in a
histocompatibility leukocyte Ag (HLA)-DM–dependent
fashion (5, 10, 11). catS is the most potent catalyst of the
CLIP generation in vitro and in vivo (12–15). Further po-
tential candidate enzymes are catF, catB, catD, and catL,
which degrade Ii in vitro (16). catF can degrade Ii in catS-
deficient murine macrophages (17), whereas catD and catB
unlikely are involved in the CLIP generation in murine
cells (13, 16). catL is the pivotal enzyme for Ii degradation
in thymic epithelial cells and, hence, is required for positive
selection of CD4
 
1
 
 thymocytes (18).
The expression levels of several cat family members are
upregulated by IL-4 and IFN-
 
g
 
 (16, 19, 20), both of which
are potent inducers of class II expression in different cell
types. Stimuli that induce DC maturation might also regu-
late the activity of proteases relevant for the generation of
exogenous Ag-derived peptides and proteases that are re-
sponsible for the generation of SDS stable class II dimers.
Along these lines, it has been suggested that the regulation
of cystatin C (Cy C) levels in DCs controls the activity of
catS in the course of maturation (21). The effects imposed
by antiinflammatory stimuli on DC function might likewise
act by controlling the levels of intracellular proteolytic ac-
tivity. IL-10 impairs class II–dependent Ag presentation in a
cell type–dependent fashion (4, 22–24) and is the prototype
cytokine that inactivates DCs in vivo and in vitro (25).
Here we asked whether protease activity is dynamically
regulated by physiologically relevant stimuli and, if so, which
are the enzymes affected. Cytokine-mediated regulation of
protease activity might help us understand how pro- and an-
tiinflammatory stimuli balance class II assembly and Ag pro-
cessing. Therefore, we examined the nature and function of
cats involved in class II–dependent Ag presentation by hu-
man DCs and analyzed the effects of pro- and antiinflamma-
tory cytokines on cat activity and T cell activation.
 
Materials and Methods
 
Abs and Reagents.
 
CBz-Tyr-Ala-CN
 
2
 
 was provided by H.
Chapman (University of California at San Francisco, San Fran-
cisco, CA) and iodinated. Anti-CD45 (MEM-28) and anti–HLA-
DR (MEM-12) mAbs were provided by V. Horejsi (Academy of
Natural Sciences, Prague, Czech Republic). Rabbit anti–cat sera
(anti-B, -L, -D, -S) were provided by E. Weber (University of
Halle-Wittenberg, Halle, Germany). 
 
N
 
-morpholinurea-leucine-
homophenylalanine-vinylsulfone-phenyl (LHVS; provided by
J.T. Palmer, Arris Pharmaceuticals, San Francisco, CA), Fmoc
YACHN
 
2
 
 (provided by R.W. Mason, Alfred I. duPont Hospital,
Wilmington, DE; reference 26), and CA074Me (Bachem
Feinchemikalien AG) were dissolved at 10 mM in DMSO and
stored at 
 
2
 
20
 
8
 
C. Chloroquine and bafilomycin A1 were from
Calbiochem.
 
Cell Preparation and Culture.
 
B cells were prepared from PBMCs
by anti-CD19 (Leu12; Becton Dickinson) immunostaining and
flow sorting (FACStar
 
PLUS™
 
; Becton Dickinson). CD34
 
1
 
-derived
DCs, and CD11c
 
1
 
 
 
and CD11c
 
2
 
 peripheral blood DCs were
prepared as described (27, 28). Monocyte-derived (md) DCs
were prepared in the presence of 1 ng/ml TGF-
 
b
 
1 (R&D Sys-
tems) in serum-free conditions (LGM3 medium; CLONTECH
Laboratories, Inc.; reference 29). mdDCs were stimulated with
100 ng/ml TNF-
 
a
 
 and 10 ng/ml IL-1
 
b
 
 (both R&D Systems; re-
ferred to as “TNF/IL-1 stimulation”). When indicated, cells were
precultured with 300 U/ml IL-10 (R&D Systems) overnight be-
fore stimulation. Tetanus toxoid (TT)-specific T cell clones
(TCCs) were established and characterized as described (30).
 
Detergent Extraction and Immunoblotting.
 
Cells were solubi-
lized, lysates were submitted to 12% SDS-PAGE, and immuno-
blotting was performed (31). mAb MEM-28 (1:5,000), rabbit anti-
actin (1:5,000; Sigma-Aldrich), or rabbit anti–cat sera (1:5,000 or
1:2,500) were incubated for 6 h. The binding of peroxidase-con-
jugated donkey anti–rabbit IgG or sheep anti–mouse IgG F(ab
 
9
 
)
 
2
 
(both 1:20,000; Amersham Pharmacia Biotech) was detected us-
ing ECLplus™ (Amersham Pharmacia Biotech).
 
Metabolic Labeling and Immunoprecipitation.
 
DCs were starved
in methionine and cysteine-free medium, pulsed for 30 min with
1 mCi/ml (5–10
 
 3 
 
10
 
6
 
 cells/ml) of InVivo Cell™ labeling mix
(Amersham Pharmacia Biotech), aliquoted, and chased at 37
 
8
 
C.
Protease inhibitors were added 4 h before pulse. Cells were lysed
at the indicated time points as described (31). Lysates were pre-
cleared with protein G beads (Sigma-Aldrich) and anti–HLA-DR
immunoprecipitation (mAb TÜ36; BD PharMingen) was per-
formed for 3 h. Precipitated proteins were eluted for 20 min with
nonreducing PAGE sample buffer containing 2% SDS. Non-
boiled and boiled aliquots of each sample were analyzed by 12%
SDS-PAGE.
 
Active-site Labeling of Cysteine Proteases.
 
0.5–1
 
 3 
 
10
 
6
 
 DCs
were stimulated with TNF/IL-1 in the presence or absence of
protease inhibitors. Cells were washed, incubated with CBz-
 
125
 
I-
Tyr-Ala-CN
 
2
 
 for 30 min at 37
 
8
 
C, washed again to remove free
label, and lysed. 12% SDS-PAGE was performed under reducing
conditions. Cellular protein content per lane was defined by the
use of equal cell numbers per sample. Even loading was con-
trolled by Coomassie blue staining of each gel.
 
Ag Degradation Assay.
 
DCs were incubated with 10 
 
m
 
g/ml of
anti-Fc
 
g
 
RII mAbs (IV.3; Medarex) for 1 h at 4
 
8
 
C, washed, and
exposed to 
 
125
 
I-labeled goat anti–mouse IgG (Amersham Pharma-
cia Biotech) for 1 h at 4
 
8
 
C. After extensive washes with cold PBS,
aliquots of 0.5
 
 3 
 
10
 
6 
 
cells were chased under various conditions.
Then cells were lysed, lysates were mixed with nonreducing sam-
ple buffer, and subjected to 10% SDS-PAGE. No signals from
[
 
125
 
I]IgG were obtained without the anti-Fc
 
g
 
RII incubation step.
Cellular protein content per lane was controlled as described.
 
Gel Densitometry.
 
The amount of SDS stable class II 
 
ab
 
dimers and of Ii fragments was defined as follows: intensity of the
respective band regions was determined from digitalized autora-
diograms using the Kodak 1D v2.02 software package (Eastman
Kodak Co.). Values obtained from the 
 
b
 
 chains of boiled precip-
itation aliquots were considered 100% for the calculation of the
amount of the corresponding SDS stable 
 
ab 
 
dimers or small leu-
peptin-induced Ii peptide (SLIP). Signal intensities from [
 
125
 
I]IgG
were quantified as described.
 
Assessment of Ag Internalization.
 
DCs were exposed to 10 
 
m
 
g/
ml biotinylated anti-Fc
 
g
 
RII or control mAbs (MOPC 21;
Sigma-Aldrich) for 30 min at 4
 
8
 
C. After washing, cells were in-
cubated with goat anti-mouse F(ab
 
9
 
)
 
2
 
 (Molecular Probes) for an- 
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other 30 min at 4
 
8
 
C to cross-link receptor-bound mAbs. Excess
F(ab
 
9
 
)
 
2
 
 was removed and internalization of surface-bound Ab
complexes was monitored after various culture periods at 37
 
8
 
C as
follows: DCs were harvested, chilled, and incubated with PE-
labeled streptavidin (1 
 
m
 
g/ml SA-PE; Becton Dickinson) for 30
min at 4
 
8
 
C. PE fluorescence was analyzed using a FACScan™
flow cytometer (Becton Dickinson) and expressed as the specific
mean fluorescence intensity (MFI; 
 
D
 
MFI, MFI of anti-Fc
 
g
 
RII
mAb-stained cells minus MFI of control mAb-stained cells). The
ratio of the 
 
D
 
MFI of DCs cultured at 37
 
8
 
C over the 
 
D
 
MFI of
DCs kept on ice multiplied by 100 gives the percentage of ligand
internalization.
 
Acidity of Endocytic Compartments.
 
DCs were exposed to anti-
Fc
 
g
 
RII mAbs followed by receptor cross-linking with FITC- or
oregon green (OG)–labeled goat anti–mouse F(ab
 
9
 
)
 
2
 
 (Molecular
Probes) at 4
 
8
 
C. Cells were washed and cultured at 37
 
8
 
C. pH-sen-
sitive FITC and pH-insensitive OG fluorescence was measured
by FACS
 
®
 
. The ratio of FITC over OG fluorescence was calcu-
lated for DCs cultured for the indicated time periods at 37
 
8
 
C.
The FITC/OG ratio of cells kept on ice was set at 100%. Ratios
determined from DCs cultured for various time periods were ex-
pressed as the percentage of this value. Results are given as the
percentage of specific reduction of FITC fluorescence relative to
the baseline value (0%; 0 h). Additionally, the pH of endocytic
DC compartments was assessed directly using LysoSensor™ yel-
low/blue conjugated to 0.25 mg/ml 10-kD dextran (Molecular
Probes; reference 32). DCs were labeled overnight in the pres-
ence or absence of IL-10. TNF/IL-1 was added for the indicated
time periods, cells were washed in PBS, and the fluorescence
emission of internalized LysoSensor™ was measured within the
next 10 min using an Axiovert 100 microscope (ZEISS) equipped
with the Attofluor™ system (Atto Instruments; excitation: 365
 
 6
 
12 nm; emission: 515–530 nm and 450–490 nm). The ratio of
green over blue emission of at least 10 randomly selected cells/
microscopic field was calculated using the Attofluor™ ratio vi-
sion software (Atto Instruments). Standard curve for intracellular
pH measurement: calibration buffer (125 mM KCl, 20 mM
NaCl, 0.5 mM CaCl
 
2
 
, 0.5 mM MgCl
 
2
 
) was titrated to pH 4 or 5
with 25 mM acetic acid, pH 6 with 25 mM MES (Merck), and
pH 7 with 25 mM morpholino propane sulfonic acid (Sigma-
Aldrich). Cells of defined intracellular pH were generated by in-
cubation with pH-adjusted calibration buffers supplemented with
10 
 
m
 
g/ml nigericin and 10 
 
m
 
g/ml monensin (Sigma-Aldrich).
Ratios of at least 10 cells/pH grade were acquired as described
above.
 
Assessment of Expression and Surface Stability of HLA-DR.
 
DCs were analyzed in parallel for surface and total cellular HLA-
DR expression by FACS
 
®
 
. For the latter analysis, cells were sub-
jected to Fix&Perm™ (An der Grub Bioresearch) and stained
with 1 
 
m
 
g/ml FITC-labeled mAb L243 (Becton Dickinson). The
surface stability of HLA-DR complexes was analyzed with bio-
tinylated Fab fragments of 10 
 
m
 
g/ml MEM-12. DCs were labeled
for 30 min at 4
 
8
 
C, washed, and cultured for the indicated time
periods at 37
 
8
 
C. Biotin moieties remaining at the cell surface
were detected with SA-PE.
 
TCR Downregulation Experiments.
 
TCR downregulation ex-
periments were performed as described with minor modifications
(33, 34). DCs were labeled with 20 nM CFDA-SE (Molecular
Probes) in PBS for 20 min at 37
 
8
 
C, washed, and incubated for 30
min with TT (Calbiochem) or TT peptides (TT
 
947–967
 
; Pichem) at
the indicated concentrations or medium only. After washing thor-
oughly DCs were chased, mixed with a TT-specific TCC (DC/T
cell ratio 4:1 in RPMI 1640, 10% human AB serum; PAA Labo-
 
ratories), and cocultured for 4 h. TCR internalization was stopped
and DC-T cell clusters were disrupted by chilling with cold PBS
and 0.5 mM EDTA. T cells were stained with PE-labeled anti-
CD3 (Leu4; Becton Dickinson) or isotype control mAbs (Becton
Dickinson) and analyzed by FACS
 
®
 
. 
 
D
 
MFI values of gated T cells
were calculated as described above and transformed to absolute
numbers of TCR/CD3 molecules per cell using the Quanti-
BRITE PE™ calibration kit (Becton Dickinson). The numbers of
triggered TCRs were calculated by subtracting the TCR/CD3
numbers of T cells cocultured with Ag-modified DCs from those
of T cells exposed to nonAg-modified DCs.
 
Results
 
DCs Acquire High Levels of Mature cats during Their Differ-
entiation from Precursors.
 
We used mdDCs as model DCs as
large cell numbers are easily accessible at an immature stage
and selected culture conditions in which mdDCs do not
produce IL-10 endogenously (29, 35). This allows a com-
parison of the effects of pro- versus antiinflammatory cy-
tokines on DC function. We first defined expression pat-
terns of cats to see whether the proteases expressed in
mdDCs were representative of human DCs.
Protease activity can be examined by at least two inde-
pendent methods. First, the level of proteases themselves
can be measured by immunochemical methods. However,
the assessment of the total protease content based on im-
munoblotting may not yield an accurate estimate of the
level of active enzyme. Therefore, the second approach is
to measure the activity of the proteases using active site–
directed, mechanism-based inhibitors. Using these two
types of approach, we addressed the changes in protease
content and activity that accompany the development and
the maturation of DCs. First, cat expression in B cells,
monocytes, various types of DCs, and DC precursors was
assessed by immunoblotting (Fig. 1 A). None of the pro-
teases analyzed (catB, catD, catL, and catS) was detectable
as the mature form in resting B cells. The only cat clearly
detected in these cells is the proform of catB, also expressed
in monocytes. Low level cat expression by resting B cells
could have escaped detection by immunoblotting. It is
equally possible that resting B cells have to undergo activa-
tion and maturation for high level cat expression. Mono-
cytes express pro-catB, pro-catL, pro- and mature catS, as
well as pro- and mature catD. During the transition from
the monocytic precursor to the immature mdDC, mature
catB is expressed de novo and several cats (mature catS,
mature catD, and pro-catL) are upregulated. Importantly,
the cat expression profile of mdDCs is virtually identical to
CD34
 
1
 
 
 
stem cell–derived DCs, and the cat pattern of
monocytes, the mdDC precursors, is similar to other well-
defined DC progenitors (28); peripheral blood CD11c
 
1
 
DC (DC1) precursors and CD11c
 
2
 
 
 
plasmacytoid DC
(DC2) precursors express the proforms of catB and catL as
well as mature catS and catD. The levels of mature en-
zymes detected are low, probably related to the relative im-
maturity of DC1 and DC2. Thus, resting DCs and DC
precursors differ in the expression levels of pro versus ma- 
884
 
Cytokines Regulate Cathepsin Activity and MHC-Peptide Display
 
ture proteases only. Our data allow the conclusion that, as
far as protease content is concerned, mdDCs (referred to as
“DC” from now on) can be used as a representative DC
population for our studies.
Do stimuli that control distinctive DC functions regulate
 
the cat expression profile of DCs? The proinflammatory,
“DC maturation–inducing” cytokines TNF-
 
a
 
 and IL-1
 
b
do not induce significant changes in the protease levels de-
tected in DCs (Fig. 1 B). Total intracellular protease con-
tent was equally insensitive to treatment with the antiin-
flammatory stimulus IL-10 alone. Expression of pro-catB
was not significantly altered by exposure of DCs to IL-10
plus TNF/IL-1. However, stimulation of IL-10–treated
cells with TNF/IL-1 lowers the levels of other proenzymes
(pro-catL, pro-catS) and downregulates the expression of
mature catB, catS, and catD within 24 h. We next analyzed
the kinetics of individual enzymatic activity levels in re-
sponse to pro- and antiinflammatory stimuli.
Pro- and Antiinflammatory Cytokines Regulate Intracellular cat
Activity in a Reciprocal Fashion. catS, catB, and catL activity
can be monitored in intact cells with the active site–directed
probe CBz-125I-Tyr-Ala-CN2. catB and catS were consti-
tutively active in resting DCs (Fig. 2 A, left). Stimulation of
DCs with TNF/IL-1 induces a rapid (within 30 min) in-
crease in the activity of catS and catB (Fig. 2, A and B, left).
No catL activity was observed in resting or activated DCs in
most experiments (in 2/20 experiments catL activity was
detected after 12 h of stimulation; data not shown). Quanti-
tative analysis (Fig. 2 A, right) demonstrates a sixfold increase
of catS activity accompanied by a moderate, but significant
(greater than twofold) induction of catB activity upon stim-
ulation with TNF/IL-1. Inclusion of 5 nM LHVS completely
blocked catS over the period of observation. Exposure of
DCs to the broad cysteine protease inhibitor leupeptin resulted
in complete loss of all detected cats (Fig. 2 A, left). Al-
though IL-10 alone does not decrease catS and catB activity in
DCs (Fig. 2 B, 0 h), it attenuates the TNF/IL-1–mediated
upregulation of catS and catB and induces a successive loss of
both active enzymes in TNF/IL-1–stimulated DCs (Fig. 2
B). In summary, these data show that proinflammatory cy-
tokines induce an immediate upregulation of enzymatic ac-
tivity that can be suppressed by the antiinflammatory stim-
ulus IL-10. Does such a cytokine-dependent regulation of
proteolytic activity affect class II processing?
Figure 1. Regulation of cat expression in DCs. (A) cat expression pro-
file of DCs and DC precursors. NP-40 lysates of equal numbers of the
indicated cell types were subjected to anti-catS, -catL, -catB, and -catD
immunoblotting. Anti-actin and -CD45 reactivity was assessed for con-
trol purposes. (B) Regulation of cat expression by pro- and antiinflam-
matory cytokines. mdDCs were incubated with IL-10 and/or TNF/IL-1
for 24 h before immunoblotting. The positions of pro and mature (m)
cats and mol wt markers (kD) are given right and left, respectively.
Figure 2. Reciprocal regulation of cat activity by cyto-
kines. (A) Proinflammatory cytokines upregulate catS and
catB activity. DCs were incubated for 4 h with or without
LHVS or leupeptin and were cultured in the presence or
absence of TNF/IL-1 for the indicated time periods. (Left)
Autoradiography of an active-site labeling experiment.
The positions of active catS and catB are indicated.
(Right) Quantification of TNF/IL-1–induced catS and
catB activities. Data are expressed as the mean percentage
cat activity (6 SEM, n = 3) in TNF/IL-1–stimulated DCs
as compared with nonstimulated controls. (B) IL-10
downregulates catS and catB activity. After overnight cul-
ture in medium (left, upper gel) or in medium containing
IL-10 (left, lower gel), DCs were exposed to TNF/IL-1
and analyzed for catS and catB activity. (Left) Representa-
tive autoradiography. (Right) Quantification of the IL-10–
induced loss of catS and catB activity. Data are expressed
as the mean percentage cat activity (6 SEM, n = 3) in IL-
10–treated DCs as compared with controls.885 Fiebiger et al.
Cytokine-induced catS Activity Mediates Rapid and Efficient
SDS Stable Class II ab Dimer Formation. We examined
the kinetics of class II maturation in TNF/IL-1–stimulated
and resting DCs by pulse-chase analysis. The metaboli-
cally labeled, nonstimulated cells maintained the HLA-
DRlowCD86lowCD832 phenotype of immature resting
DCs and responded to TNF/IL-1 stimulation equally well
as nonlabeled DCs (data not shown). Immunoprecipita-
tions were performed at the indicated time points from cell
number–adjusted aliquots of metabolically labeled DCs us-
ing the HLA-DR–specific mAb TÜ36. This mAb recog-
nizes HLA-DR-ab bound to full-length Ii (splice variants
p31/33, p41, and the highly sialylated form of p41, p47), or
to Ii remnants (SLIP, leupeptin-induced Ii peptide [LIP],
CLIP), as well as HLA-DR-ab–peptide complexes. Fig. 3
A shows the rapid formation of SDS stable class II ab
dimers in TNF/IL-1–activated DCs. After a 2-h chase,
stimulated DCs already contained 36% of the total HLA-
DR-b–bound radioactivity in SDS stable HLA-DR-ab
dimers (average, n = 3). This value increases to 73% after
16 h (Fig. 3 B). In contrast, in resting DCs (Fig. 3 E) SDS
stable class II dimers appear slowly and rather inefficiently
(only 36% of HLA-DR-b incorporated radioactivity in
SDS stable dimers after 16 h). Dimer formation by resting
DCs is hardly affected by catS blockade (Fig. 3, E and G)
and few SLIP fragments accumulate when LHVS is added
to the culture (Fig. 3 F). This finding is consistent with the
rather low level of catS activity of resting DCs, as detected
with CBz-125I-Tyr-Ala-CN2 (Fig. 2 A). LHVS-mediated
inhibition of catS in activated DCs induces the accumula-
tion of SLIP (Fig. 3, A and C) and a pronounced, but tem-
porary, inhibition in the generation of SDS stable class II
dimers (Fig. 3, A and B). These findings correlate well with
the activation-induced upregulation of catS activity (Fig.
2). In summary, the wave of MHC class II SDS stable
dimer formation induced by TNF/IL-1 (Fig. 3 D) depends
on and is mediated by the immediate upregulation of catS
activity seen in response to such treatment.
IL-10 Alters Class II Processing by Modulating cat Activity.
Is the observed IL-10–mediated downregulation of cat
activity relevant for Ii degradation and SDS stable class II
ab dimer formation? TNF/IL-1–stimulated DCs, either
unmodified or precultured in IL-10– or LHVS-containing
medium, were metabolically labeled and subjected to
HLA-DR immunoprecipitation. As expected, inhibition of
catS by LHVS induces accumulation of SLIP (Fig. 4 A).
SLIP appears in precipitates from IL-10–exposed but not
from control DCs (Fig. 4 A). Since catS is the major en-
zyme that can effectively digest SLIP in TNF/IL-1–stimu-
lated DCs, it appears that IL-10 impairs catS activity such
that it affects class II maturation. Indeed, exposure of DCs
to IL-10 leads to a delay in SDS stable dimer formation
(Fig. 4 B), but has no effect on the synthesis of the class II
subunits themselves (Fig. 4 A). Thus, it appears that the
temporary accumulation of SLIP in stimulated, IL-10–
treated DCs is because of the combined action of the
TNF/IL-1–mediated increase in class II synthesis and the
attenuated catS activity in response to IL-10.
As IL-10 suppresses not only catS but also catB activity,
we assessed the relative impact of either protease on class II
maturation. For this purpose, the catB- and the catS-spe-
cific inhibitors CA074Me and LHVS were used to create
Figure 3. Cytokine-induced catS activity mediates efficient SDS stable class II dimer formation. (A) Metabolically labeled DCs were chased in TNF/
IL-1–containing medium in the presence or absence of LHVS and subjected to anti–HLA-DR immunoprecipitation. Nonboiled (NB) and boiled (B)
precipitates were analyzed by SDS-PAGE. The positions of free HLA-DR-a (a) and b chains (b), Ii isoforms (p33, p41, p47), SDS stable HLA-DR-ab
dimers (ab), and LHVS-induced SLIP are indicated. (B–G) Pulse-chase immunoprecipitation experiments from TNF/IL-1–stimulated (B–D) and resting
DCs (E and F) in the presence (d) or absence of LHVS (s). The radioactivity incorporated into SDS stable dimers (B and E) or into SLIP (C and F) is
expressed as the percent of the total HLA-DR-b–bound radioactivity (ordinate; mean % 6 SEM, n = 3). (D and G) catS-dependent class II dimer forma-
tion expressed as the difference between the SDS stable dimers in control and LHVS-treated cells (ordinate). Abscissa shows the chase time.886 Cytokines Regulate Cathepsin Activity and MHC-Peptide Display
catB- and/or catS-deficient cells (Fig. 4 C) for pulse-chase
analysis. 100 nM CA074Me did not influence or only mod-
erately influenced catS activity during the 16-h chase period
(4-h time point in Fig. 4 C). In agreement with our earlier
results, catS but not catB mediates rapid SDS stable dimer
formation in cytokine-stimulated DCs. Our conclusion that
dimers that form late during the chase period rely on catB
rather than catS activity is, however, based on the assump-
tion that CA074Me does not prevent the activation and
maturation of enzymes other than catB. DCs deficient for
both enzymes show reduced dimer formation during the
entire time period analyzed (Fig. 4 D). This temporal reso-
lution of the individual enzyme’s contributions suggests that
they serve discrete functions in the class II pathway. Ac-
cordingly, LHVS, but not CA074Me, induces the accumu-
lation of Ii remnants (Figs. 2 and 4, and data not shown).
IL-10 Inhibits Ag Degradation by DCs. To further char-
acterize the functional importance of catB in DCs, we
asked whether pharmacological or cytokine-mediated
modulation of catB results in impaired Ag degradation and,
consequently, altered peptide display. Digestion of iodi-
nated IgG internalized via FcgRII was used to investigate
Ag degradation by DCs. Equal numbers of Ag-loaded cells
were chased for various time periods and fragmentation
patterns of internalized IgG were analyzed. TNF/IL-1
treatment increases the capacity of DCs to degrade Ag, as
judged from the accelerated disappearance of both full-
length IgG and its fragments (Fig. 5 A). IL-10 treatment of
nonstimulated cells was without visible effect (data not
shown). When IL-10–treated DCs were stimulated with
TNF/IL-1, their Ag degradation capacity changed consid-
erably (Fig. 5 B). Untreated and IL-10–treated DCs inter-
nalized IgG with virtually identical kinetics and efficacy
(Fig. 5 C) excluding the possibility of prolonged Ag persis-
tence at the cell surface. In stimulated DCs, intact Ag has a
t1/2 of z1 h and degradation products are hardly discernible
(Fig. 5 B). The presence of IL-10 increases the t1/2 of intact
Ag to .8 h and protein fragments ranging from 20 to 60
kD become prominent (Fig. 5, B and D). Similar to the re-
sults seen in the FcgRII targeting experiments, the degra-
Figure 4. Role of IL-10 and catB for SDS stable class II dimer forma-
tion. (A and B) IL-10 delays SDS stable dimer formation. DCs cultured in
the presence or absence of LHVS for 4 h or IL-10 (overnight) were stim-
ulated with TNF/IL-1 for 4 h, metabolically labeled, and chased under
prelabeling culture conditions. Immunoprecipitated class II complexes
were analyzed by SDS-PAGE. (A) Representative autoradiography. (B)
Quantification of SDS stable dimer formation in IL-10–treated (d) and
control DCs (s). The radioactivity incorporated into SDS stable dimers is
expressed as the percent of the total HLA-DR-b–bound radioactivity
(ordinate; mean % 6 SEM, n = 3). Abscissa gives the chase time. (C) Se-
lective elimination of catS and/or catB activity in DCs. DCs were incu-
bated with or without LHVS, CA074Me, or both inhibitors for 4 h. cat
activity was analyzed using CBz-125I-Tyr-Ala-CN2. The inhibition pro-
file remained constant for .16 h (data not shown). (D) catB activity con-
tributes to SDS stable dimer formation. DCs were exposed to LHVS (u),
CA074Me (j), the combination of both (d), or medium only (s) and
stimulated with TNF/IL-1 for 4 h and then subjected to pulse-chase
immunoprecipitation as described. The radioactivity incorporated into
SDS stable dimers is expressed as the percentage of the total HLA-DR-
b–bound radioactivity (ordinate; mean % 6 SEM, n = 3). Abscissa gives
the chase time.
Figure 5. IL-10 inhibits Ag degradation but not Ag uptake. (A–D)
DCs were cultured in the presence or absence of IL-10 overnight. When
indicated, DCs were stimulated with TNF/IL-1 for 4 h. Cells were ex-
posed to anti-FcgRII mAbs followed by 125I-labeled goat anti–mouse IgG
(A and B) or biotinylated anti-FcgRII mAbs followed by goat anti–
mouse F(ab9)2 at 48C (C) and chased under prelabeling conditions. The
degradation of iodinated IgG was followed by nonreducing 10% SDS-
PAGE (A and B). Mol wt markers in kD on the left. (C) The internaliza-
tion of biotinylated IgG via FcgRII was assessed by SA-PE labeling and
FACS®. The percentage of Ag internalized (ordinate) by IL-10–treated
(d) and control DCs (s) (mean percentage of two experiments) is de-
picted as a function of the chase time (abscissa). (D) Quantification of
[125I]IgG degradation by IL-10–treated (d) and control DCs (s). The
percentage of intact IgG (ordinate) is depicted as a function of the pro-
cessing time (abscissa; mean % 6 SEM, n = 3).887 Fiebiger et al.
dation of IgG taken up via the mannose receptor pathway
of macropinocytosis (36) was inhibited by IL-10 although
internalization rates were not at all affected (data not
shown). We conclude that IL-10 indeed inhibits the Ag
degrading capacity of DCs.
IL-10 Inhibits Ag Degradation by Inhibiting catB Activity and
by Modulating the pH of Endocytic DC Compartments. Do
specific cat inhibitors and IL-10 induce similar Ag frag-
mentation patterns? If so, a comparison between inhibitor-
and IL-10–treated cells could provide further clues as to the
key protease(s) involved. IL-10 treatment of DCs induces
the accumulation of IgG fragments in the range from 20 to
60 kD (Fig. 6 A). Although 100 nM CA047Me selectively
inhibited catB in our experimental setting (Fig 4 C), a sin-
gle mode of interference still may not be sufficient to allow
definitive conclusions about the function of this enzy-
matic activity (37). Thus, we decided to use three indepen-
dent strategies to block catB, i.e., exposure of DCs to (a)
CA047Me (38), (b) the catB/catL–specific inhibitor Fmoc
YACHN2 (26), and (c) a high concentration of LHVS
(0.5 mM) that eliminates catB, catL, and catS activity
(12, 16, 39). Each condition produced an Ag fragmenta-
tion pattern quantitatively and qualitatively similar to IL-
10–exposed DCs (Fig. 6 A). Thus, these fragments are
attributable to IL-10–mediated inhibition of catB. catS and
catL are not required for Ag degradation in the presence of
active catB. catS and catL become important only in the
absence of active catB. This is seen from the accumulation
of fragments ,30 kD in catL/catB– and catS/catB–double
deficient cells to an extent similar to IL-10–exposed DCs.
Data from cat B2/2 mice show only a modest shift in the
efficiency of presentation of certain antigenic determinants
indicative for a minor role of this protease for Ag degrada-
tion in murine splenocytes (40). Our results with human
DCs differ from this observation and underline again the
importance of studying defined populations of APCs in
their own sight. In summary, we conclude that catB is a
major Ag-degrading protease of human DCs and, further,
that catB activity is negatively regulated by IL-10.
Since the pH of endo/lysosomal compartments is a criti-
cal factor regulating the activity and stability of cats (16, 41),
we asked whether IL-10 inhibits protease activities in DCs
by elevating the pH of the endocytic pathway. DCs were
labeled with mouse mAbs to FcgRII followed by anti–
mouse Abs coupled to a low pH-sensitive dye (FITC), and
pH-dependent FITC quenching, which accompanies li-
gand internalization, was monitored (Fig. 6 B). In the
presence of IL-10, intracellular FITC quenching was strik-
ingly reduced whereas the kinetics and efficacy of ligand in-
ternalization were not affected (Fig. 6 B). Using quanti-
tative ratio measurements of fluorescence emission, we
further demonstrate directly that endo/lysosomal compart-
ments of IL-10–treated stimulated DCs are less acidic than
those of control cells (Fig. 6 C). Calculations based on the
standard curve show that the average pH in endocytic com-
partments changes from pH 4.5 to 5.3 (data not shown).
Do drugs that raise the pH of the endo/lysosomal system
reproduce the effects of IL-10 in DCs? DCs were exposed
to the lysosomotropic drugs bafilomycin or chloroquine
and monitored for their cat activity, their total intracellular
protease content, and for their Ag degradation capacity.
Active-site labeling shows that catB and catS activity are
massively downregulated upon exposure of DCs to either
of the pH-modulating drugs (Fig. 6 D). Both compounds
Figure 6. IL-10 inhibits catB-mediated Ag degradation and modulates the pH of endocytic DC compartments. (A) IL-10 inhibits Ag degradation by
inhibiting catB activity. DCs were cultured in the presence or absence of IL-10 overnight or were exposed for 4 h to bafilomycin, CA074Me, LHVS (5,
50, or 200 nM; indicated by the wedge), CA074Me plus LHVS (5 nM), or FmocYACHN2 in the presence of TNF/IL-1. Next DCs were labeled with
anti-FcgRII/125I-goat anti–mouse IgG and allowed to process Ag for 2 h at 378C. The fragmentation pattern of [125I]IgG in the # 65-kD range is shown.
(B) Internalized immune complexes experience a less acidic milieu in DCs exposed to IL-10. DCs cultured in the presence (d) or absence of IL-10 (s)
were exposed to TNF/IL-1 for 4 h. Then cells were labeled with biotinylated anti-FcgRII and goat anti–mouse F(ab9)2, or with FcgRII followed by
FITC- or OG-labeled goat anti–mouse F(ab9)2, and chased under prelabeling conditions for the indicated time peroids (abscissa). On the ordinate, the
percentage of the ligand internalization (broken lines; mean, n = 2) and of the pH-dependent reduction of ligand fluorescence (solid lines; mean 6 SEM,
n = 3) is shown. (C) IL-10 increases the pH of endocytic DC compartments. DCs were loaded with LysoSensor™-coupled dextran in the presence or
absence of IL-10 overnight and then exposed to TNF/IL-1 for 6 h. The endosomal pH of DCs either exposed (lower) or not exposed to IL-10 (upper)
was determined microscopically and is shown in a pH color code. (D) catB and S activity is downregulated by reagents that raise endosomal pH. DCs
were cultured for 4 h in the presence or absence of bafilomycin, or chloroquine in TNF/IL-1–supplemented medium, and subjected to active-site label-
ing. Positions of catS and catB are shown.888 Cytokines Regulate Cathepsin Activity and MHC-Peptide Display
significantly lower the total intracellular protein levels of
mature catB and catS in DCs as assayed by immunoblotting
(data not shown). Importantly, DCs exposed to bafilomy-
cin were largely incapable of degrading intact Ag taken up
via FcgRII and showed accumulation of a major 50-kD
IgG fragment also prominent in IL-10–treated and catB-
deficient DCs (Fig. 6 A). According to the literature, IL-6
acidifies endosomes in DCs (42). Our data suggest that IL-
10, by raising endo/lysosomal pH, induces the opposite ef-
fect. Indeed, IL-6 reverses the IL-10–induced impairment
of Ag degradation (data not shown). Thus, we conclude
that regulation of endosomal pH by IL-10 contributes to
the control of proteolytic activity.
IL-10 Prevents Long-Term Delivery of a TCR Signal.
TNF/IL-1–induced accumulation of HLA-DR at the cell
surface is clearly impaired by IL-10 as determined by
FACS® (Fig. 7 A). Likewise, leupeptin treatment results in
reduced class II surface expression upon exposure to TNF/
IL-1 (Fig. 7 A). In contrast, neither IL-10 nor leupeptin
clearly affects the surface expression of HLA-DR in resting
DCs (Fig. 7 A, time point 0), the TNF/IL-1–induced up-
regulation of total cellular HLA-DR (Fig. 7 B), and the
stimulation-induced downregulation of macropinocytotic
Ag uptake (data not shown). Reduced HLA-DR surface
expression seen in IL-10–treated DCs most likely involves
an export defect since internalization of class II from the
cell surface was not enhanced by IL-10 or leupeptin (Fig. 7
C, and data not shown). These results strengthen the inter-
pretation that IL-10 affects class II trafficking by regulating
lysosomal protease function and not simply by preventing
TNF/IL-1–induced activation of DCs.
To analyze the impact of IL-10 on the surface display of
class II–bound peptides, we exploited internalization of
newly engaged TCRs as a measure of specific class II–pep-
tide display (43). Activated DCs were pulsed with TT or
TT peptides and analyzed for their capacity to trigger
TCRs of TT-specific TCCs. The kinetics of peptide-
induced TCR triggering by IL-10–treated DCs is compa-
rable to untreated cells (Fig. 7 D), yet the extent to which
downregulation of the TCR occurs is markedly less. The
lower level of TCR triggering by IL-10–treated DCs must
correspond to their reduced display of HLA-DR loaded
with TT peptides at the cell surface. As expected, TCR
downregulation by peptide-pulsed DCs occurs instanta-
Figure 7. IL-10 inhibits export and display of class II–peptide com-
plexes. (A and B) IL-10 inhibits export but not synthesis of class II. DCs
were cultured overnight in the presence of IL-10 (d), leupeptin (m), or
medium only (s), and then stimulated with TNF/IL-1. Intact (A) and
permeabilized cells (B) were subjected to anti–HLA-DR immunolabeling.
Specific MFI (ordinate) are plotted against the time of TNF/IL-1 stimula-
tion (abscissa). (C) Internalization of class II from the cell surface is not al-
tered by IL-10. DCs cultured in the presence (d) or absence of IL-10 (s)
were exposed to TNF/IL-1 for 4 h. Cells were labeled with biotinylated
anti–HLA-DR Fab and chased under prelabeling culture conditions. The
percentage of biotinylated mAb remaining at the cell surface is shown (or-
dinate) as the function of time (abscissa). (D and E) IL-10 inhibits the
long-term display of full protein-derived, class II–associated peptides. DCs
cultured in the presence (closed symbols) or absence of IL-10 (open sym-
bols) were exposed to TNF/IL-1 for 4 h. Cells were pulsed with TT (50
and 5 nM; circles in D and E, respectively) or 1 nM TT peptide (TTpep;
squares in D) and chased under prepulsing culture conditions. During the
last 4 h, cells were cocultured with TT-specific T cells. The absolute
numbers of triggered TCRs (ordinate) are plotted against the time of pro-
cessing (abscissa). Representative experiment (n = 4).
Figure 8. Quantification of the TCR signaling deficit imposed by IL-
10. (A) The numbers of triggered TCRs and the logarithm of the con-
centration of pulsed Ag are correlated in a linear fashion. Short-term
TNF/IL-1–stimulated DCs were pulsed with TT (j) or TT peptide (m)
at the indicated concentrations (abscissa). Cells were cultured for 8 h un-
der prepulsing conditions and TT-dependent TCR triggering (ordinate)
was assessed. The linear regression analysis for TT and TT peptide is
shown. (B) IL-10 modulates the magnitude and duration of the TCR sig-
nal. DCs either exposed to IL-10 (closed symbols) or not exposed (open
symbols) were pulsed with 5 nM (circles) or 50 nM TT (squares), and
chased for the indicated time periods (abscissa). The ordinate shows the
display of MHC class II–peptide complexes by IL-10-modified DCs
(DC10; mean % 6 SEM, n = 3) relative to control DCs (DCCO). The
relative numbers of MHC class II–peptide complexes transported to the
cell surface was calculated using the formula: relative class II–peptide dis-
play = [e(TCRs triggered by DC10)/e(TCRs triggered by DCCO)] 1/K. K is the constant
defining the slope of the regression curve describing the correlation be-
tween the concentration of pulsed Ag and the number of triggered
TCRs. K is not influenced by IL-10 (data not shown).889 Fiebiger et al.
neously and decays during the chase. In contrast, TCR
triggering by TT-pulsed DCs requires .1 h of processing
of TT, but thereafter increases constantly over hours to
days (Fig. 7 D, and data not shown). The level and kinetics
of processing-dependent presentation of TT are signifi-
cantly altered by IL-10 exposure of DCs (Fig. 7 E). Until 7 h
after the pulse, similar numbers of TCRs are triggered by
IL-10–treated and control DCs. Thereafter, the TCR-trig-
gering capability of IL-10–exposed DCs drops. No additive
defect in peptide presentation was observed when DCs
were exposed to IL-10 and catB inhibitors simultaneously
(data not shown), supporting the role of IL-10 in regula-
tion of catB activity.
To quantify the IL-10 effect on class II–peptide display,
DCs were pulsed with various concentrations of TT or TT
peptides and the numbers of TCRs triggered by these cells
were measured. We observed a strictly linear correlation
between the numbers of triggered TCRs and the logarithm
of the concentrations of intact protein Ag as well as peptide
used during the pulse (Fig. 8 A). The two regression curves
are parallel, indicating that synthetic peptides and the pep-
tides generated from TT protein by DCs are incorporated
into class II complexes of comparable TCR triggering ca-
pacity. A linear correlation exists between the logarithm of
the absolute number of class II–peptide complexes dis-
played and the number of TCRs triggered (33). Therefore,
we conclude that a linear correlation exists also between
the Ag concentration encountered by the DC and the ab-
solute number of MHC class II–peptide complexes trans-
ported to the cell surface. Consequently, when the mea-
sured numbers of triggered TCRs (ordinate; Fig. 8 A) are
projected onto the TT regression curve, the value obtained
on the abscissa is a direct measure of the number of MHC
class II–peptide complexes displayed by the DC.
IL-10–exposed and control DCs were pulsed with 5 or
50 nM TT and assayed for their TCR triggering capacity
after various chase periods. IL-10 strikingly reduces the t1/2,
but less so the amplitude, of the signal delivered by DCs to
the TCR (Fig. 8 B). Importantly, the inhibitory effect of
IL-10 on class II-peptide display was equally pronounced at
5 and 50 nM TT. The peptide-bound class II ab com-
plexes formed initially disappear from the cell surface with
a t1/2 of 12–15 h (Fig. 8 B) and with kinetics strikingly sim-
ilar to those of class II molecules loaded with synthetic pep-
tide (Fig. 7 D, and data not shown). In summary, IL-10
prevents the continuous formation of peptide–class II com-
plexes and/or their export from the endo/lysosomal system
and, as a result, directly affects T cell activation.
Discussion
For DCs to evoke a primary T cell response, processing
of internalized Ag and proper maturation of MHC class II
complexes are essential. We have examined the nature and
function of cats capable of mediating these events in md-
DCs as examples of professional APCs. This choice is vali-
dated by our observation that the cat expression pattern of
mdDCs is representative of other types of DCs. We show
that Ag processing and class II maturation are controlled by
at least two proteases with discrete functions, catS and catB.
DCs almost instantaneously upregulate the activity of both
enzymes in response to proinflammatory cytokines, an ef-
fect counteracted by the antiinflammatory cytokine IL-10.
Based on the use of specific inhibitors we conclude that
catS is one of the major enzymes that generates SDS stable
class II dimers in human DCs. The catS-dependent path-
way of class II dimer formation operates efficiently when
DCs encounter proinflammatory cytokines and is inhibited
by IL-10. Class II SDS stable dimer formation in DCs is
sensitive to catS inhibition by LHVS, but only early in the
course of biosynthesis. Furthermore LHVS-induced accu-
mulation of SLIP and catS-dependent dimer formation
show strikingly similar kinetics.
In the absence of proinflammatory stimuli, DCs display
baseline catS activity and do not accumulate class II–SLIP
complexes. This situation differs from that described for
immature murine bone marrow–derived DCs, which accu-
mulate SLIP and are therefore thought to be devoid of catS
activity (21). In this regard, our observation underscores
the differences between human and murine APCs. Active
catS mediates SLIP degradation in resting human DCs, as
seen from the immediate accumulation of SLIP induced by
LHVS treatment. Nonetheless LHVS-exposed, cytokine-
activated DCs still show SLIP degradation and SDS stable
dimer formation, but at a reduced rate, suggesting the in-
volvement of other unidentified proteases. catF, a SLIP de-
grading enzyme in mouse macrophages (17), is an obvious
candidate for this phenomenon. LHVS at 20 nM, a con-
centration shown to interfere with catF activity (17), was
unable to abolish SLIP degradation in our experimental
system (data not shown). The lack of cell-permeable, catF-
specific probes renders functional studies on a possible con-
tribution of catF difficult at the moment. Our data clearly
show that catS is used preferentially when DCs are acti-
vated. Then its activity and importance for SDS stable
dimer formation clearly exceeds that of the other presum-
ably less efficient enzymes.
Proinflammatory stimuli evoke rapid formation of pep-
tide-loaded class II dimers by upregulating cat activity,
whereas antiinflammatory stimuli like IL-10 counteract
this. The fast increase (within 30 min) in protease activity
in response to TNF/IL-1 rather excludes transcriptional
regulation as the underlying mechanism. Although still to
be proven experimentally, it is likely that relocalization of
(pro)enzymes into compartments with pH levels that favor
enzymatic activity occurs in a cell activation–dependent
fashion. According to the literature (21), Cy C is involved
in the inhibition of cat activity in murine DCs. Thus, we
investigated whether cytokines that modulate cat activity
also regulate the expression or the subcellular distribution
of this endogenous cat inhibitor. However, neither immu-
noblotting nor confocal laser scanning microscopy revealed
significant changes in Cy C levels or localization in re-
sponse to any of the applied cytokines (data not shown). In
summary, our data argue against the possibility that Cy C is
involved in cytokine-mediated cat regulation in human DCs.890 Cytokines Regulate Cathepsin Activity and MHC-Peptide Display
The decrease in cat activity by IL-10 is physiologically
relevant, as demonstrated by the reduced ability of IL-10–
treated DCs to activate T cells. catB’s major enzymatic tar-
gets are Ags that enter DCs via macropinocytosis (mannose
receptor dependent) or via coated pits and vesicles (FcgRII
mediated). IL-10 inhibits the degradation of both full-
length protein Ags and Ag fragments. Pharmacologic inhi-
bition of catB, but not of catS or catL activity, similarly in-
hibits Ag degradation. Some Ag breakdown products
appear early after Ag loading in IL-10–treated and pharma-
cologically catB-depleted DCs. Enzymes that may attack
complex protein Ag include asparaginyl endopeptidase, a
protease implicated in TT cleavage (6, 44). Our observa-
tion that full protein Ag persists while the Ag fragments
formed initially decay in IL-10–treated DCs shows that the
activity of these proteases is attenuated by IL-10.
The alteration of the intracompartmental pH may con-
tribute to the inhibition of cat activity by IL-10. IL-10 can
influence the pH of Ag-loading compartments, as demon-
strated by increased acidification of mycobacterial phago-
somes in macrophages from IL-10 knockout mice and, vice
versa, decreased acidification upon exposure of susceptible
cells to this cytokine (45). We show that internalized Ags
experience a less acidic milieu in DCs exposed to IL-10.
Pharmacological inhibition of acidification mimics the IL-
10–induced defect in Ag degradation. Whereas the expres-
sion of proteases that are more stable at a pH close to neu-
tral is hardly affected, IL-10 treatment downregulates the
mature form of those proteases that require acidic pH for
their stability (catD, catB; reference 41). Thus, inhibition
of enzymatic activities induced by IL-10 most likely in-
cludes pH-regulated maturation and activation, pH-depen-
dent autocatalytic degradation, and, for some proteases, the
release into extracellular space (46). IL-10 could addition-
ally affect cellular functions not yet addressed, i.e., the traf-
ficking of Ags or proteases towards class II loading com-
partments. Moreover, it is expected that the functional
program activated by exposure of DCs to IL-10 is highly
complex. Array-based transcriptional profiling may be
helpful in defining this program, and in turn, may allow a
more directed cell biological analysis of IL-10’s inhibitory
effects on Ag presentation.
We used the TCR triggering assays for a semiquantita-
tive estimate of peptide display by cytokine-modified DCs.
Titration and kinetics revealed that pro and antiinflamma-
tory cytokines regulate the levels of surface class II peptide
display by DCs in a differential manner. Remarkably, a
simple mathematical term describes the relationship be-
tween the concentration of Ag/peptide pulsed onto the
DC and the number of TCRs engaged during a cognate
DC–T cell interaction. The logarithm of the Ag and pep-
tide concentration and the number of triggered TCRs cor-
relate in linear fashion. The number of class II–peptide
complexes on the APC surface and the number of engaged
TCRs are also correlated in semilogarithmic fashion (43).
Therefore DCs convert extracellular Ag into surface-dis-
posed class II peptide complexes with constant molar effi-
cacy. The fact that serial triggering of TCRs is most effi-
cient when the APC expresses one or only few class II
complexes containing the relevant peptide renders the class
II display measurement extremely sensitive. The linear re-
gression calculated for the display of peptides derived from
TT intersects the abscissa at an Ag concentration of ,10210
M. Thus, on average, each DC displays one TT peptide at
an Ag concentration of z10210 M. DCs internalize extra-
cellular fluid equal to their own volume (z2.5 3 10213 l)
in z1 h (36). Based on the assumption that the major in-
ternalization mechanism for TT by DCs is fluid-phase up-
take (47), we calculate that a DC pulsed with 10210 M TT
(i.e., 6.023 3 1013 molecules/liter) for 30 min internalizes
1.3 3 10213 liter of the solute, equivalent to z8 TT mole-
cules. The internalization of this small number of intact Ag
molecules suffices to trigger several hundred Ag-specific
TCRs. We observed that TNF/IL-1–stimulated DCs ex-
press approximately twice the amount of TT peptide–bear-
ing class II complexes when compared with unstimulated
controls after a short Ag pulse (data not shown). The ability
of unstimulated DCs to display TT peptide in the context
of class II was described previously (1). In contrast, others
observed that stimulated but not unstimulated murine DCs
can present a peptide derived from a hen egg lysozyme (48,
49). In summary, these findings support previous sugges-
tions that human DCs and murine bone marrow–derived
DCs differ in terms of their Ag processing and presentation
machinery (16, 50). IL-10 causes a dramatic change in pep-
tide–class II display on the surface of DCs. Whereas pep-
tide–class II display is only partially reduced during the first
hours after the Ag pulse, long-term display of the com-
plexes is essentially aborted in IL-10–exposed cells. The
decay of peptide presentation by protein Ag-pulsed, IL-10–
treated DCs equals peptide-pulsed DCs. The Ag presenta-
tion defect imposed by IL-10 therefore results from inhibi-
tion of formation or export, and not destabilization, of
peptide–class II complexes. Thus, we, attribute limited
peptide availability during the late phase of Ag presentation
to IL-10–mediated protease inhibition.
Immunologically naive T cells require TCR stimulation
at suprathreshold intensity for .30 h before they become
committed to proliferation and cytokine production (43,
51). Our findings suggest that the suppressive action of IL-
10 on T cell activation may result in premature termination
of TCR signals. Ag-specific tolerization of T cells by IL-10
has been attributed mainly to suppression of costimulation.
When costimulation is limited, as found in connection
with exposure to IL-10, the magnitude and duration of sig-
nals via the TCR decide whether Ag-specific T cell anergy
or activation occurs (52). Thus, naive T cells that receive a
TCR signal at subthreshold intensity or duration too short
to induce their functional commitment may become aner-
gic. If this interpretation of the effects of IL-10 were cor-
rect, then indeed manipulating protease activities could be
useful to paralyze pathogenic T cells.
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